Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShort-Term Debt repayments
Ratios

bioAffinity Technologies (BIAF) Accumulated Depreciation & Amortization (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Accumulated Depreciation & Amortization for 4 consecutive years, with $580012.0 as the latest value for Q1 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization changed N/A to $580012.0 in Q1 2025 year-over-year; TTM through Mar 2025 was $580012.0, a N/A change, with the full-year FY2024 number at $536251.0, up 43.72% from a year prior.
  • Accumulated Depreciation & Amortization was $580012.0 for Q1 2025 at bioAffinity Technologies, up from $536251.0 in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $580012.0 in Q1 2025 to a low of $800.0 in Q3 2022.
  • A 4-year average of $357011.8 and a median of $342770.0 in 2023 define the central range for Accumulated Depreciation & Amortization.
  • Peak YoY movement for Accumulated Depreciation & Amortization: surged 38.61% in 2023, then soared 43.72% in 2024.
  • bioAffinity Technologies' Accumulated Depreciation & Amortization stood at $269180.0 in 2022, then soared by 38.61% to $373123.0 in 2023, then skyrocketed by 43.72% to $536251.0 in 2024, then rose by 8.16% to $580012.0 in 2025.
  • Per Business Quant, the three most recent readings for BIAF's Accumulated Depreciation & Amortization are $580012.0 (Q1 2025), $536251.0 (Q4 2024), and $493446.0 (Q3 2024).